Michael Morris, MD, director of Cardiac MR and Cardiac CT at Banner Health and Wesley O'Neal, MD, director of cardiac CT and nuclear cardiology at Cone Health, discuss the results of SMART-CT Study.

Join us for an expert panel webinar on the just-released PRECISE Trial 1-year results that showed using coronary CTA with FFRCT Analysis to evaluate suspected coronary artery disease offers more accurate non-invasive diagnosis, fewer unnecessary tests and higher confidence among physicians in identifying patients needing treatment. The data demonstrates AHA/ACC Chest Pain Guideline-directed CCTA plus FFRCT Precision Pathway is superior to traditional testing. Watch now!